Terms: = Lymphoma AND MYH11, ENSG00000133392, 4629 AND Prognosis
16 results:
1. Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype.
Marcault C; Boissel N; Haferlach C; Loschi M; Raynaud S; Cluzeau T
Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):e199-e205. PubMed ID: 34674982
[TBL] [Abstract] [Full Text] [Related]
2. The clinical mutatome of core binding factor leukemia.
Opatz S; Bamopoulos SA; Metzeler KH; Herold T; Ksienzyk B; Bräundl K; Tschuri S; Vosberg S; Konstandin NP; Wang C; Hartmann L; Graf A; Krebs S; Blum H; Schneider S; Thiede C; Middeke JM; Stölzel F; Röllig C; Schetelig J; Ehninger G; Krämer A; Braess J; Görlich D; Sauerland MC; Berdel WE; Wörmann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
Leukemia; 2020 Jun; 34(6):1553-1562. PubMed ID: 31896782
[TBL] [Abstract] [Full Text] [Related]
3. ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
Yang X; Shi J; Zhang X; Zhang G; Zhang J; Yang S; Wang J; Ke X; Fu L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028135
[TBL] [Abstract] [Full Text] [Related]
4. The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in
Park SH; You E; Park CJ; Jang S; Cho YU; Yoon CH; Koh KN; Im HJ; Seo JJ
Ann Lab Med; 2019 Jul; 39(4):358-366. PubMed ID: 30809981
[TBL] [Abstract] [Full Text] [Related]
5. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract] [Full Text] [Related]
6. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract] [Full Text] [Related]
7. Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.
Matsuo H; Iijima-Yamashita Y; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):41-46. PubMed ID: 29067751
[TBL] [Abstract] [Full Text] [Related]
8. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
[TBL] [Abstract] [Full Text] [Related]
9. Common leukemia- and lymphoma-associated genetic aberrations in healthy individuals.
Song J; Mercer D; Hu X; Liu H; Li MM
J Mol Diagn; 2011 Mar; 13(2):213-9. PubMed ID: 21354057
[TBL] [Abstract] [Full Text] [Related]
10. [Identification of gene rearrangements in childhood leukemia by using a multiplex polymerase chain reaction-microarray approach].
Wu J; Zhang LP; Cheng YF; Lu AD; Liu GL; Chen SH; Wang SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):908-12. PubMed ID: 19698227
[TBL] [Abstract] [Full Text] [Related]
11. Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia.
Pakakasama S; Kajanachumpol S; Kanjanapongkul S; Sirachainan N; Meekaewkunchorn A; Ningsanond V; Hongeng S
Int J Lab Hematol; 2008 Aug; 30(4):286-91. PubMed ID: 18665825
[TBL] [Abstract] [Full Text] [Related]
12. A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse.
Lane S; Saal R; Mollee P; Jones M; Grigg A; Taylor K; Seymour J; Kennedy G; Williams B; Grimmett K; Griffiths V; Gill D; Hourigan M; Marlton P
Leuk Lymphoma; 2008 Mar; 49(3):517-23. PubMed ID: 18297529
[TBL] [Abstract] [Full Text] [Related]
13. Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia.
Yanada M; Terakura S; Yokozawa T; Yamamoto K; Kiyoi H; Emi N; Kitamura K; Kohno A; Tanaka M; Tobita T; Takeo T; Sao H; Kataoka T; Kobayashi M; Takeshita A; Morishita Y; Naoe T; Sugiura I
Leuk Lymphoma; 2004 Sep; 45(9):1803-8. PubMed ID: 15223639
[TBL] [Abstract] [Full Text] [Related]
14. Molecular analysis of a new variant of the CBF beta-myh11 gene fusion.
Stulberg J; Kamel-Reid S; Chun K; Tokunaga J; Wells RA
Leuk Lymphoma; 2002 Oct; 43(10):2021-6. PubMed ID: 12481902
[TBL] [Abstract] [Full Text] [Related]
15. Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases.
Cascavilla N; Melillo L; D'Arena G; Greco MM; Carella AM; Sajeva MR; Perla G; Matera R; Minervini MM; Carotenuto M
Leuk Lymphoma; 2000 Mar; 37(1-2):105-13. PubMed ID: 10721774
[TBL] [Abstract] [Full Text] [Related]
16. The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.
Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Callen DF
Leuk Lymphoma; 1996 Feb; 20(5-6):357-64. PubMed ID: 8833390
[TBL] [Abstract] [Full Text] [Related]